Literature DB >> 3390827

Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.

J L Mohler1, A W Partin, J T Isaacs, D S Coffey.   

Abstract

A method for accurate prediction of prognosis in individual patients with prostatic carcinoma does not exist. The limitations of pathological grading systems may result from the failure of standard pathological examination of fixed dead tissue to accurately assess the biological and metastatic behavior of live tumor cells. Many of the sublines of the Dunning R-3327 rat prostatic adenocarcinoma are histologically similar yet differ in metastatic potential. Cells from the Dunning model were grown in culture and filmed by time-lapse videomicroscopy. These cells exhibited characteristic membrane ruffling, pseudopodal extension, and cellular translation that could be graded with 80% reproducibility. Individual cells from sublines with high metastatic potential were separated from cells from sublines of low metastatic potential in 96% of cases. We have applied our cell motility grading system to prospectively classify the metastatic potential of neoplastic cells. The mean motility grades of sublines of high and low metastatic potential differed significantly (Mann-Whitney-Wilcoxon, P less than 0.0005). Among seven sublines in which the grading system was developed, individual cells were correctly classified as high or low metastatic in 71% of cases by ruffling or pseudopodal extension, 73% of cases by translation, and 75% of cases by motility index, an average of the three parameters of motility. Among four newly tested sublines, cells from a low metastatic and high metastatic sublines were perfectly classified. Cells from two other low metastatic sublines were misclassified. When all 88 cells from the 11 sublines were classified, high metastatic cells were detected with 94% sensitivity and 50% specificity. The predictive value of a determination of low metastatic was 93%, whereas the predictive value of an assignment of high metastatic was 52%. The ability to detect and accurately classify most highly metastatic cells while rarely erring in a classification of low metastatic potential suggests that a grading system of cancer cell motility should be evaluated in human prostatic carcinoma. The motility of live prostatic carcinoma cells may predict patient prognosis better than standard pathological grading systems.

Entities:  

Mesh:

Year:  1988        PMID: 3390827

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Transformation-related expression of a low-molecular-mass tropomyosin isoform TM5/TM30nm in transformed rat fibroblastic cell lines.

Authors:  K Miyado; M Sato; S Taniguchi
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Thymosin beta15 expression in tumor cell lines with varying metastatic potential.

Authors:  L Bao; M Loda; B R Zetter
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

Review 3.  Cellular motility and prostatic carcinoma metastases.

Authors:  J L Mohler
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

4.  An anti-invasive concentration of the alkyl-lysophospholipid ET-18-OCH3 enhances the motility of embryonal chick heart cells cultured on solid substrate.

Authors:  N A van Larebeke; E A Bruyneel; M M Mareel
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

Review 5.  A brief history of intracrine androgen metabolism by castration-recurrent prostate cancer.

Authors:  James L Mohler
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

6.  The spread of human lung cancer cells on collagens and its inhibition by type III collagen.

Authors:  K Hirai; H Shimada; T Ogawa; S Taji
Journal:  Clin Exp Metastasis       Date:  1991 Nov-Dec       Impact factor: 5.150

7.  Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model.

Authors:  J L Mohler; W E Bakewell; Y Sharief; W B Coleman; C H Chay; S M Silvers; G J Smith
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

8.  Biometric assessment of prostate cancer's metastatic potential.

Authors:  C R Cooper; N Emmett; S Harris-Hooker; R Patterson; D B Cooke
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates.

Authors:  S H Lang; M Stower; N J Maitland
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

10.  Quantitative measurement of cell motility associated with transformed phenotype.

Authors:  M Tatsuka; S Jinno; T Kakunaga
Journal:  Jpn J Cancer Res       Date:  1989-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.